Docetaxel+Oxali+/-Cetux Met Gastric/GEJ

Inclusion Criteria: * Patient has histologically confirmed Stage IV adenocarcinoma of the GEJ/stomach Note: Adjuvant radiation plus treatment with 5-FU and leucovorin is permitted, but not required. * Patients must have measurable disease * Patient has an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0-2 * Patient is greater than 18 years of age * If present, any pre-existing (current) peripheral neuropathy must be ≤ Grade 1 * Patient's laboratory values must fall within the limits set forth in section 4.2 of the protocol * Patient has a negative serum pregnancy test within 7 days prior to registration (female patients of childbearing potential) * If fertile, patient (male or female) has agreed to use an acceptable method of birth control to avoid pregnancy for the duration of the study and for a 2 month period thereafter * Patient (or guardian) has signed a Patient Informed Consent Form * Patient (or guardian) has signed a Patient Authorization Form Exclusion Criteria: * Patient has any metastatic disease other than that defined in section 4.2 (criterion #1) * Patient has had prior treatment that included anything other than adjuvant radiation plus treatment with 5-FU and leucovorin. Prior treatment must have been completed \> 6 months prior to registration in current study. No other prior regimens are allowed. Note: Adjuvant radiation plus treatment with 5-FU and leucovorin is permitted, but not required. * If present, any peripheral neuropathy is \> Grade 1 * Patient has a known hypersensitivity to Taxotere (or any drug formulated with Polysorbate-80), or Eloxatin * Has had a prior severe infusion reaction (Grade 4) to a monoclonal antibody * Has received prior therapy, at any time, which specifically and directly targets the EGFR pathway * Patient is receiving concurrent immunotherapy or any other concurrent treatment for their cancer * Has had prior stem cell or bone marrow transplant or any organ transplant with the exception of corneal transplant or cadaver bone graft * Has a significant history of uncontrolled cardiac disease; ie, uncontrolled hypertension, unstable angina, recent myocardial infarction (within prior 6 months), uncontrolled congestive heart failure, or cardiomyopathy with decreased ejection fraction (LVEF\<50%) * Has evidence of CNS involvement (CNS imaging is not required for study enrollment unless clinically suspected CNS disease is present.) * Patient has a serious uncontrolled intercurrent medical or psychiatric illness, including serious infection * Patient is known to be HIV positive or have a history of hepatitis B or C * Patient has a history of other malignancy within the last 5 years (except for squamous or basal cell carcinoma of the skin, carcinoma in situ of the cervix , or superficial transitional cell carcinoma of the bladder), which could affect the diagnosis or assessment of current condition. * Patient is a pregnant or lactating woman